TDAC
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Shell Companies · US
$10.85
−0.09%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$10.86
From 52W high−0.46%
Volume12510.00
Market cap$209.50M
P/E (TTM)42.1x
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$10.86
From 52W high
−0.46%
Volume
12510.00
Market cap
$209.50M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−159.7x
P/E (TTM)
42.1x
RSI (14)
54.6
MomentumView details →
1D Return
−0.09%
YTD Return
+3.62%
Similar companies
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.54d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.76d ago